Wild Swing Trades 📈

VRDN Swing Trade Setup: Neutral RSI Pullback Offers Measured Long Opportunity on June 22, 2026 VRDN Swing Trade Setup: Neutral RSI Pullback Offers Measured Long Opportunity on June 22, 2026 Published: June 22, 2026 • Personal Trading Playbook 56/100 Conviction Score 1:2 Risk / Reward +5.5% Expected Value 1–2% Suggested Alloc. AI Execution Summary: Viridian Therapeutics (VRDN) stands at a pivotal inflection point on June 22, 2026, with its lead asset veligrotug (VRDN-001) under FDA Priority Review and a PDUFA target action date of June 30, 2026-just eight days away. The stock trades near $16.63 after a modest pullback on elevated volume, creating a compelling technical setup for a catalyst-driven swing. Positive Phase 3 data from THRIVE and THRIVE-2 in active and chronic thyroid eye disease (TED) support a potential approval that could unlock significant upsid...

June 22, 2026 Personal Trading Playbook ELF Beauty (NYSE: ELF) Neutral RSI & Short-Term Support Create Measured Swing Opportunity at $62-63 Risk Disclaimer: This analysis is for educational and informational purposes only and does not constitute financial, investment, or trading advice. Trading involves substantial risk of loss. Only risk capital you can afford to lose. Past performance is not indicative of future results. Executive Summary Live Reference $62.24 Session Change -3.05% Daily Volume 1,476,759 Core Catalyst Overview e.l.f. Beauty operates exclusively in cosmetics and skincare (no medical PDUFA tracks). Core intermediate drivers feature its Fall 2026 milestone pipeline innovation drops paired with rhode's high-profile commercial launch across 19 European Sephora markets, driving incremental international numb...

JOBY Flying Taxis Ready To Take Off Published: June 22, 2026 • Personal Trading Playbook 49/100 Conviction Score 1:1.9 Risk / Reward +11.0% Expected Value 1 - 2% Suggested Alloc. AI Execution Summary: JOBY shows a moderate-conviction setup featuring an asymmetric risk-to-reward edge of 1:1.9. Price action has reclaimed the psychologically crucial $10 level on elevated volume. Timing is highly optimized with price floating just 1.1% from the planned structural reload zone. Trade Execution Matrix Trade Scenario Entry Trigger Exit / Target Point Return Profile Probability Base Case (Target 1) $9.73 $10.77 +10.7% 48% Bull Case (Target 2) $9.73 $12....

JOBY — Playbook & Thesis 2026-06-22 • Personal Trading Playbook JOBY — Playbook & Thesis JOBY — Expanded Analysis & Plan Risk Disclaimer: This is not financial advice. Trading involves substantial risk of loss. Only risk capital you can afford to lose. Past performance is not indicative of future results. Executive Summary Published: June 22, 2026 | Technical Swing Analysis PDUFA Catalyst Joby has completed Stage 4 of the FAA type certification process (testing and analysis), with Stage 5 (show and verify) now underway. Key near-term milestones include ongoing Type Inspection Authorization (TIA) flight testing by FAA pilots expected later in 2026, full type certificate issuance targeted for late 2026, and parallel air carrier certification plus vertiport readiness for initial commercial operations. Dubai launch remains a leading candidate for early 2026 service, supported by ongoing General Civil Aviation Author...

HPE — Weak swing playbook 2026-06-22 • Personal Trading Playbook HPE — Weak swing playbook HPE — Expanded Analysis & Plan Risk Disclaimer: This is not financial advice. Trading involves substantial risk of loss. Only risk capital you can afford to lose. Past performance is not indicative of future results. Executive Summary Published: June 22, 2026 | Technical Analysis & Trade Plan PDUFA Catalyst HPE does not have traditional PDUFA or FDA regulatory milestones as it operates in enterprise infrastructure rather than biotech. Key near-term catalysts include follow-through from the June 1, 2026 Q2 earnings beat and raised guidance, the HPE Discover 2026 event (June 16, 2026) highlighting agentic AI and self-driving networks with NVIDIA, and ongoing AI order momentum expected to drive Q3 results. Additional potential triggers involve further networking-for-AI announcements and any updates on the Juniper integration syne...

Behind the Scenes of a Quant Lab: Building an Automated Trading Pipeline In modern swing trading, consistency, speed, and risk management separate profitable systems from chaotic discretionary trading. A highly sophisticated trading laboratory relies on automation to screen tickers, compute precise execution levels, estimate hit probabilities, and generate readable research reports. Here is a conceptual look inside a three-tier manufacturing assembly line for financial intelligence. Phase 1: Finding the Geometric Blueprint (The Backbone) The first layer of the system operates on the mathematical philosophy that markets have memory and move in structural cycles. It removes human emotion, rumors, and news from the equation, focusing strictly on the historical physics of price action. Locating Extremes: The system looks at a specific window of time to establish a definitive S...

CAT Surges to Fresh All-Time Highs: High-Probability Bullish Swing Setup on Strong Volume Breakout 2026-06-21 • Personal Trading Playbook CAT Surges to Fresh All-Time Highs: High-Probability Bullish Swing Setup on Strong Volume Breakout CAT — Expanded Analysis & Plan Risk Disclaimer: This is not financial advice. Trading involves substantial risk of loss. Only risk capital you can afford to lose. Past performance is not indicative of future results. Executive Summary Published: June 21, 2026 | Technical Analysis & Swing Trade Plan for CAT PDUFA Catalyst CAT has no traditional PDUFA or FDA regulatory milestones as an industrial equipment manufacturer. Key near-term catalysts instead include the Q2 2026 earnings release scheduled for August 4, 2026, with analyst EPS estimates around $6.16, and the CONEXPO 2026 trade show showcasing new AI and autonomy technologies. Additional momentum stems from ongoing AI infrastructure tailwinds and potential updates on the re...

SLI Playbook & Thesis Published: June 21, 2026 • Personal Trading Playbook 31/100 Conviction Score 1:1 Risk / Reward +10.8% Expected Value 0 - 0.5% Suggested Alloc. AI Execution Summary: The framework indicates a weak or non-compelling setup overall with a narrow 1:1 edge. Price is currently sitting 8.2% away from the preferred reload zone—traders should wait for a structural reset before sizing in. Trade Execution Matrix Trade Scenario Entry Trigger Exit / Target Point Return Profile Probability Base Case (Target 1) $3.69 $3.96 +7.3% 55% Bull Case (Target 2) $3.69 $4.41 +19.5% 35% Bear Cas...

VRDN — Playbook & Thesis 2026-06-21 • Personal Trading Playbook VRDN — Playbook & Thesis VRDN — Expanded Analysis & Plan Risk Disclaimer: This is not financial advice. Trading involves substantial risk of loss. Only risk capital you can afford to lose. Executive Summary Published: June 21, 2026 | Technical Analysis & Trade Plan PDUFA Catalyst The primary near-term catalyst is the FDA's target action date of June 30, 2026, for veligrotug's BLA in thyroid eye disease (TED) under Priority Review. The application was accepted in late 2025 and granted Breakthrough Therapy Designation earlier. No additional PDUFA extensions or delays have been announced as of June 21, 2026. Secondary readouts include topline Phase 3 data for elegrobart (VRDN-003) in active TED (REVEAL-1) expected in Q1 2026 and chronic TED (REVEAL-2) in Q2 2026, with potential BLA submission for the subcutaneous asset by year-en...